Cargando…
Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
Glioblastoma (GBM) is a highly malignant and aggressive primary brain tumor mostly prevalent in adults and is associated with a very poor prognosis. Moreover, only a few effective treatment regimens are available due to their rapid invasion of the brain parenchyma and resistance to conventional ther...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734213/ https://www.ncbi.nlm.nih.gov/pubmed/33329578 http://dx.doi.org/10.3389/fimmu.2020.592612 |